Literature DB >> 12163571

Molecular characterization of preintegration latency in human immunodeficiency virus type 1 infection.

Theodore C Pierson1, Yan Zhou, Tara L Kieffer, Christian T Ruff, Christopher Buck, Robert F Siliciano.   

Abstract

Most current evidence suggests that the infection of resting CD4(+) T cells by human immunodeficiency virus type 1 (HIV-1) is not productive due to partial or complete blocks in the viral life cycle at steps prior to integration of the viral genome into the host cell chromosome. However, stimulation of an infected resting T cell by antigen, cytokines, or microenvironmental factors can overcome these blocks and allow for the production of progeny virions. In this study, we sought to understand the structure and fate of the virus in unstimulated resting CD4(+) T cells. Using a novel linker-mediated PCR assay designed to detect and characterize linear unintegrated forms of the HIV-1 genome, we demonstrate that reverse transcription can proceed to completion following the infection of resting T cells, generating the substrate for the retroviral integration reaction. However, reverse transcription in resting T cells is far slower than in activated T cells, requiring 2 to 3 days to complete. The delay in completing reverse transcription may make the viral DNA genome more susceptible to competing decay processes. To explore the relationship between the formation of the linear viral genome and the stability of the preintegration state, we employed a recombinant HIV-1 virus expressing the enhanced green fluorescent protein to measure the rate at which HIV-1 decays in the preintegration state. Our results demonstrate that the preintegration state is labile and decays rapidly (half-life = 1 day) following the entry of HIV-1 into a resting T cell, with significant decay occurring during the slow process of reverse transcription.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12163571      PMCID: PMC136977          DOI: 10.1128/jvi.76.17.8518-8513.2002

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  48 in total

1.  Contingent genetic regulatory events in T lymphocyte activation.

Authors:  G R Crabtree
Journal:  Science       Date:  1989-01-20       Impact factor: 47.728

2.  Reverse transcription takes place within extracellular HIV-1 virions: potential biological significance.

Authors:  H Zhang; Y Zhang; T P Spicer; L Z Abbott; M Abbott; B J Poiesz
Journal:  AIDS Res Hum Retroviruses       Date:  1993-12       Impact factor: 2.205

3.  Nucleotide sequence analysis of the long terminal repeat (LTR) of avian retroviruses: structural similarities with transposable elements.

Authors:  G Ju; A M Skalka
Journal:  Cell       Date:  1980-11       Impact factor: 41.582

4.  Restriction endonuclease and nucleotide sequence analyses of molecularly cloned unintegrated avian tumor virus DNA: structure of large terminal repeats in circle junctions.

Authors:  R A Katz; C A Omer; J H Weis; S A Mitsialis; A J Faras; R V Guntaka
Journal:  J Virol       Date:  1982-04       Impact factor: 5.103

5.  Establishment of a stable, inducible form of human immunodeficiency virus type 1 DNA in quiescent CD4 lymphocytes in vitro.

Authors:  C A Spina; J C Guatelli; D D Richman
Journal:  J Virol       Date:  1995-05       Impact factor: 5.103

6.  Hydroxyurea as an inhibitor of human immunodeficiency virus-type 1 replication.

Authors:  F Lori; A Malykh; A Cara; D Sun; J N Weinstein; J Lisziewicz; R C Gallo
Journal:  Science       Date:  1994-11-04       Impact factor: 47.728

7.  Intravirion reverse transcripts in the peripheral blood plasma on human immunodeficiency virus type 1-infected individuals.

Authors:  H Zhang; O Bagasra; M Niikura; B J Poiesz; R J Pomerantz
Journal:  J Virol       Date:  1994-11       Impact factor: 5.103

8.  Cellular tropism of the human retrovirus HTLV-III/LAV. I. Role of T cell activation and expression of the T4 antigen.

Authors:  J S McDougal; A Mawle; S P Cort; J K Nicholson; G D Cross; J A Scheppler-Campbell; D Hicks; J Sligh
Journal:  J Immunol       Date:  1985-11       Impact factor: 5.422

9.  Nascent human immunodeficiency virus type 1 reverse transcription occurs within an enveloped particle.

Authors:  H Zhang; Y Zhang; T Spicer; D Henrard; B J Poiesz
Journal:  J Virol       Date:  1995-06       Impact factor: 5.103

10.  Cytokine signals are sufficient for HIV-1 infection of resting human T lymphocytes.

Authors:  D Unutmaz; V N KewalRamani; S Marmon; D R Littman
Journal:  J Exp Med       Date:  1999-06-07       Impact factor: 14.307

View more
  128 in total

Review 1.  Latency in human immunodeficiency virus type 1 infection: no easy answers.

Authors:  Deborah Persaud; Yan Zhou; Janet M Siliciano; Robert F Siliciano
Journal:  J Virol       Date:  2003-02       Impact factor: 5.103

2.  Resting CD4+ T cells from human immunodeficiency virus type 1 (HIV-1)-infected individuals carry integrated HIV-1 genomes within actively transcribed host genes.

Authors:  Yefei Han; Kara Lassen; Daphne Monie; Ahmad R Sedaghat; Shino Shimoji; Xiao Liu; Theodore C Pierson; Joseph B Margolick; Robert F Siliciano; Janet D Siliciano
Journal:  J Virol       Date:  2004-06       Impact factor: 5.103

3.  Kinase control prevents HIV-1 reactivation in spite of high levels of induced NF-κB activity.

Authors:  Frank Wolschendorf; Alberto Bosque; Takao Shishido; Alexandra Duverger; Jennifer Jones; Vicente Planelles; Olaf Kutsch
Journal:  J Virol       Date:  2012-02-15       Impact factor: 5.103

Review 4.  Advances in the field of lentivector-based transduction of T and B lymphocytes for gene therapy.

Authors:  Cecilia Frecha; Camille Lévy; François-Loïc Cosset; Els Verhoeyen
Journal:  Mol Ther       Date:  2010-08-24       Impact factor: 11.454

Review 5.  Quiescent T cells and HIV: an unresolved relationship.

Authors:  Dimitrios N Vatakis; Christopher C Nixon; Jerome A Zack
Journal:  Immunol Res       Date:  2010-12       Impact factor: 2.829

6.  Concerted action of cellular JNK and Pin1 restricts HIV-1 genome integration to activated CD4+ T lymphocytes.

Authors:  Lara Manganaro; Marina Lusic; Maria Ines Gutierrez; Anna Cereseto; Giannino Del Sal; Mauro Giacca
Journal:  Nat Med       Date:  2010-02-21       Impact factor: 53.440

7.  G-->A hypermutation in protease and reverse transcriptase regions of human immunodeficiency virus type 1 residing in resting CD4+ T cells in vivo.

Authors:  Tara L Kieffer; Patty Kwon; Richard E Nettles; Yefei Han; Stuart C Ray; Robert F Siliciano
Journal:  J Virol       Date:  2005-02       Impact factor: 5.103

Review 8.  Defective virus drives human immunodeficiency virus infection, persistence, and pathogenesis.

Authors:  Diana Finzi; Susan F Plaeger; Carl W Dieffenbach
Journal:  Clin Vaccine Immunol       Date:  2006-07

9.  Rapid expression of human immunodeficiency virus following activation of latently infected cells.

Authors:  Philip A Arlen; David G Brooks; Lian Y Gao; Dimitrios Vatakis; Helen J Brown; Jerome A Zack
Journal:  J Virol       Date:  2006-02       Impact factor: 5.103

10.  Determinants of the establishment of human immunodeficiency virus type 1 latency.

Authors:  Alexandra Duverger; Jennifer Jones; Jori May; Frederic Bibollet-Ruche; Frederic A Wagner; Randall Q Cron; Olaf Kutsch
Journal:  J Virol       Date:  2009-01-14       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.